Genflow Biosciences PLC (GENF)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

2.05p

Buy

2.15p

arrow-down-0.025p (-1.18%)

Prices updated at 17 Jun 2026, 15:48 BST

Prices minimum 15 mins delay

Prices in GBX

Genflow Biosciences PLC is a preclinical biotechnology company focused on the development of biological interventions (namely gene therapies) which are aimed at tackling the effects of aging, potentially slowing or halting the aging process and so red ...

FTSE All-Share

0.14%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Gad Berdugo

CEO

Dr. Eric J. Leire

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

5

Head office

6 Heddon Street

London

United Kingdom

W1B 4BT

-

info@genflowbio.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Gad Berdugo Non-Executive Director, Chairman	-
Dr. Yassine Bendiabdallah Non-Executive Director	-
Dr. Guy-Charles Fanneau de la Horie Non-Executive Director	-
Dr. Eric J. Leire Executive Director, Chief Executive Officer	-
Ms. Tamara L. Joseph Executive Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
1741 Fund Services S.A.	470,633
Plutos- Wealth One	470,633
Miton Asset Management Limited	-
Premier Miton UK Smaller Companies	-

Director dealings

Date chevron-l-regular chevron-r-regular	Action
11 Mar 2026	Purchase
11 Mar 2026	Purchase
16 Oct 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.